济民健康：双鸽集团解除质押1764万股

Group 1 - The core point of the news is that Jimin Health (SH 603222) announced the release of 17.64 million shares from pledge by its major shareholder, Shuangge Group, which holds approximately 123 million shares, accounting for 23.38% of the total share capital [1] - After the release of the pledge, Shuangge Group has a total of 76.5 million shares pledged, which is 62.32% of its holdings and 14.57% of the total share capital [1] - The combined shareholding of Shuangge Group and its concerted parties is about 229 million shares, representing 43.52% of the total share capital [1] Group 2 - As of the announcement, Jimin Health's market capitalization is 5.4 billion yuan [2] - For the first half of 2025, Jimin Health's revenue composition is as follows: 52.07% from the pharmaceutical manufacturing sector, 46.01% from the medical services sector, 1.54% from pharmaceutical trading, and 0.38% from other businesses [1]